Cytek Biosciences Stock Market Capitalization
| CTKB Stock | USD 6.22 0.02 0.32% |
Cytek Biosciences fundamentals help investors to digest information that contributes to Cytek Biosciences' financial success or failures. It also enables traders to predict the movement of Cytek Stock. The fundamental analysis module provides a way to measure Cytek Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cytek Biosciences stock.
| Last Reported | Projected for Next Year | ||
| Market Cap | 1.2 B | 2.2 B |
Cytek | Market Capitalization |
Cytek Biosciences Company Market Capitalization Analysis
Cytek Biosciences' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Cytek Biosciences Market Capitalization | 813.84 M |
Most of Cytek Biosciences' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cytek Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cytek Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Cytek Biosciences is extremely important. It helps to project a fair market value of Cytek Stock properly, considering its historical fundamentals such as Market Capitalization. Since Cytek Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cytek Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cytek Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Cytek Market Capitalization Historical Pattern
Today, most investors in Cytek Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cytek Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cytek Biosciences market capitalization as a starting point in their analysis.
Cytek Biosciences Market Capitalization |
| Timeline |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Cytek Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of Cytek Biosciences is about 813.84 M. This is 93.71% lower than that of the Health Care Equipment & Supplies sector and 92.64% lower than that of the Health Care industry. The market capitalization for all United States stocks is 95.72% higher than that of the company.
Cytek Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cytek Biosciences' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cytek Biosciences could also be used in its relative valuation, which is a method of valuing Cytek Biosciences by comparing valuation metrics of similar companies.Cytek Biosciences is currently under evaluation in market capitalization category among related companies.
Cytek Fundamentals
| Return On Equity | -0.0297 | ||||
| Return On Asset | -0.0325 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 562.84 M | ||||
| Shares Outstanding | 131.26 M | ||||
| Shares Owned By Insiders | 8.66 % | ||||
| Shares Owned By Institutions | 65.11 % | ||||
| Number Of Shares Shorted | 7.47 M | ||||
| Price To Book | 2.01 X | ||||
| Price To Sales | 4.10 X | ||||
| Revenue | 193.01 M | ||||
| Gross Profit | 100.97 M | ||||
| EBITDA | (17.11 M) | ||||
| Net Income | (12.15 M) | ||||
| Cash And Equivalents | 349.89 M | ||||
| Cash Per Share | 2.60 X | ||||
| Total Debt | 33.17 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 10.47 X | ||||
| Book Value Per Share | 3.01 X | ||||
| Cash Flow From Operations | 5.28 M | ||||
| Short Ratio | 10.02 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 676 | ||||
| Beta | 1.37 | ||||
| Market Capitalization | 813.84 M | ||||
| Total Asset | 497.67 M | ||||
| Retained Earnings | (29.18 M) | ||||
| Working Capital | 335.83 M | ||||
| Net Asset | 497.67 M |
About Cytek Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cytek Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytek Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytek Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Cytek Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytek Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cytek Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytek Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytek Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytek Biosciences to buy it.
The correlation of Cytek Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytek Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytek Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytek Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cytek Biosciences Piotroski F Score and Cytek Biosciences Altman Z Score analysis. For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Cytek Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytek Biosciences. If investors know Cytek will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytek Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.658 | Earnings Share (0.09) | Revenue Per Share 1.427 | Quarterly Revenue Growth 0.205 | Return On Assets (0.03) |
The market value of Cytek Biosciences is measured differently than its book value, which is the value of Cytek that is recorded on the company's balance sheet. Investors also form their own opinion of Cytek Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cytek Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytek Biosciences' market value can be influenced by many factors that don't directly affect Cytek Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytek Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytek Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytek Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.